Check-Cap CEO to Present at LD Micro Main Event on December 2, 2015

Nov 25, 2015, 07:00 ET from Check-Cap Ltd.

ISFIYA, Israel, Nov. 25, 2015 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ:   CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that Bill Densel, Check-Cap's Chief Executive Officer, will present at the LD Micro 8th Annual Main Event on December 2, 2015 in Los Angeles, CA.

Mr. Densel will provide an overview of the Check-Cap system, which is being developed as the world's first system for less-invasive and preparation-free examination of the interior of the colon to identify precancerous polyps and cancers. Mr. Densel will also discuss the Company's ongoing clinical study in Europe and Israel. Preliminary data from this trial were recently presented at both the American College of Gastroenterology (ACG) Annual Scientific Meeting, as well as at the United European Gastroenterology (UEG) Week.

About Check-Cap

Check-Cap is a clinical stage medical diagnostics company developing the first system for preparation-free imaging of the inner colon to identify precancerous polyps and cancers while being less invasive than traditional procedures. The Company is developing an ingestible capsule that utilizes proprietary, ultra-low-dose X-ray technology to safely generate high-resolution, 3-dimensional imagery of the interior of the colon. Without requiring bowel preparation or diet and activity modifications, Check-Cap's system is designed to increase patient acceptance and adherence to colorectal cancer screening recommendations. The Check-Cap system is currently not cleared for marketing in any jurisdiction.

Legal Notice Regarding Forward-Looking Statements

This press release contains "forward-looking statements." Words such as "may," "should," "could," "would," "predicts," "potential," "continue," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and similar expressions, as well as statements in future tense, often signify forward-looking statements.  Forward-looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will be achieved.  Forward-looking statements are based on information that the Company has when those statements are made or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements.  For a discussion of these and other risks that could cause such differences and that may affect the realization of forward-looking statements, please refer to the "Special Note On Forward-looking Statements" and "Risk Factors" in the Company's Annual Report on Form 20-F and other filings with the Securities and Exchange Commission (SEC). Investors and security holders are urged to read these documents free of charge on the SEC's web site at  The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.


David Carey
Lazar Partners Ltd.

Vivian Cervantes
PCG Advisory Group

Danielle Lewis
Lazar Partners Ltd.


SOURCE Check-Cap Ltd.